Evofem Biosciences Inc

OTC Pink - Current Information:EVFMUnited States

Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company. It is engaged in developing and commercializing products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). Its product, Phexxi vaginal gel, is a hormone-free, woman-controlled, on-demand prescription contraceptive gel for women. Its lead clinical program is evaluating Phexxi (using the investigational name EVO100) for the prevention of chlamydia and gonorrhea in women. EVO200 vaginal gel (EVO200), its investigational candidate for the reduction of recurrent bacterial vaginosis (BV), uses the same vaginal potential of hydrogen (pH) modulator platform as Phexxi. It also focuses on developing Multipurpose Prevention Technology (MPT) vaginal gel for indications, including the prevention of human immunodeficiency virus (HIV) in women through Orion Biotechnology Canada Ltd.

Contact Information

Headquarters

12400 High Bluff Dr Ste 600SAN DIEGO, CA, United States 92130-3077

Phone

858-550-1900

Fax

858-750-1013

Executives

President, Chief Executive Officer, Director

Saundra Pelletier

Chief Financial Officer

Justin File

Executive Vice President, General Counsel, Secretary

Alexander Fitzpatrick

Independent Director

Gillian Greer

Independent Director

Kim Kamdar